Algernon Logo 1.png
Algernon Pharmaceuticals Announces Small Cell Lung Cancer Ifenprodil Research Program and Appoints Dr. William North as Lead Consultant
11 août 2021 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
Algernon Logo 1.png
Algernon Pharmaceuticals Announces Exclusive Licensing Agreement with Dartmouth College
09 août 2021 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
1555102157573_5c7ea78883c747000486abc8_logo.jpg
Qrons Extends Sponsored Research Agreement with Dartmouth College
11 nov. 2019 08h00 HE | Qrons Inc.
Supports Continued Research for the Development of Innovative 3D Printable, Biocompatible Advanced Materials, and Stem Cell Delivery Techniques for Traumatic Brain Injuries  NEW YORK, NY, Nov. 11,...
External Remote Patient Monitoring Devices Market Well Prepared To Meet Futuristic Demands Of Healthcare At Home - MarketIntelReports
26 mars 2017 11h30 HE | Market Intel Reports LLP
Wilmington, Delaware, United States, March 26, 2017 (GLOBE NEWSWIRE) -- The report “External Remote Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2016”, available on...